NCT00416533View on ClinicalTrials.gov

Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

October 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

DRUG

doxorubicin hydrochloride

DRUG

prednisone

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00416533 - Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter